Skip to main content
. 2015 Jun 16;2015(6):CD007872. doi: 10.1002/14651858.CD007872.pub3

Comparison 1. Tranexamic acid versus placebo/no treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Blood loss > 400 mL or > 500 mL 6 1398 Risk Ratio (M‐H, Random, 95% CI) 0.52 [0.42, 0.63]
1.1 Tranexamic acid in vaginal birth 3 832 Risk Ratio (M‐H, Random, 95% CI) 0.42 [0.28, 0.63]
1.2 Tranexamic acid in caesarean section 3 566 Risk Ratio (M‐H, Random, 95% CI) 0.55 [0.44, 0.69]
2 Blood loss > 1000 mL 6 2093 Risk Ratio (M‐H, Fixed, 95% CI) 0.40 [0.23, 0.71]
2.1 Tranexamic acid in vaginal birth 2 559 Risk Ratio (M‐H, Fixed, 95% CI) 0.28 [0.06, 1.36]
2.2 Tranexamic acid in caesarean section 4 1534 Risk Ratio (M‐H, Fixed, 95% CI) 0.43 [0.23, 0.78]
3 Mean blood loss (mL) 5 1186 Mean Difference (IV, Fixed, 95% CI) ‐77.79 [‐97.95, ‐57.64]
3.1 Tranexamic acid in vaginal birth 3 832 Mean Difference (IV, Fixed, 95% CI) ‐80.56 [‐104.80, ‐56.33]
3.2 Tranexamic acid in caesarean section 2 354 Mean Difference (IV, Fixed, 95% CI) ‐71.57 [‐107.89, ‐35.26]
4 Use of additional medical interventions to control PPH 5 2049 Risk Ratio (M‐H, Fixed, 95% CI) 0.48 [0.34, 0.68]
4.1 Tranexamic acid in vaginal birth 2 559 Risk Ratio (M‐H, Fixed, 95% CI) 0.35 [0.16, 0.72]
4.2 Tranexamic acid in caesarean section 3 1490 Risk Ratio (M‐H, Fixed, 95% CI) 0.54 [0.36, 0.81]
5 Use of additional surgical interventions to control PPH 4 2051 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.1 Tranexamic acid in vaginal birth 1 439 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Tranexamic acid in caesarean section 3 1612 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Blood transfusion 6 1698 Risk Ratio (M‐H, Fixed, 95% CI) 0.24 [0.11, 0.53]
6.1 Tranexamic acid in vaginal birth 1 439 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.03, 3.17]
6.2 Tranexamic acid in CS 5 1259 Risk Ratio (M‐H, Fixed, 95% CI) 0.23 [0.10, 0.54]
7 Maternal death or severe maternal morbidity such as seizure, thromboembolic events, need for intensive care unit admission, hysterectomy, organ failure 4 1511 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.1 Tranexamic acid in vaginal birth 2 559 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Tranexamic acid in caesarean section 2 952 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Side effects 8 2616 Risk Ratio (M‐H, Random, 95% CI) 2.48 [1.36, 4.50]
8.1 Tranexamic acid in vaginal birth 3 740 Risk Ratio (M‐H, Random, 95% CI) 1.96 [1.50, 2.55]
8.2 Tranexamic acid in caesarean section 5 1876 Risk Ratio (M‐H, Random, 95% CI) 3.78 [0.69, 20.66]
9 Thromboembolic events 11 3012 Risk Ratio (M‐H, Fixed, 95% CI) 0.98 [0.14, 6.78]
9.1 Tranexamic acid in vaginal birth 2 559 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Tranexamic acid for caesarean section 9 2453 Risk Ratio (M‐H, Fixed, 95% CI) 0.98 [0.14, 6.78]